The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review)

Oncology Reports

Volumn 5, Issue 5, 1998, Pages 1043-1052

  Engelhardt, Monika ^a   Martens, Uwe M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Immortalization; Replicative aging; Telomerase

Indexed keywords

BINDING PROTEIN; DNA POLYMERASE; PRIMER RNA; RIBONUCLEOPROTEIN; TELOMERASE;

CANCER; CELL AGING; CELL IMMORTALIZATION; CONTROLLED STUDY; DNA SYNTHESIS; FEEDBACK SYSTEM; GENETIC STABILITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOMATIC CELL; TELOMERE; TUMOR CELL;

EID: 0031854960     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.5.1043     Document Type: Review

References (109)

1. Muller HJ: The remaking of chromosomes. Collecting Net 13: 181-195, 1938.
2. McClintock B: The stability of broken ends of chromosomes of Zea mays. Genetics 26: 234-282, 1941.
3. Blackburn EH and Gall JG: A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J Mol Biol 120: 33-53, 1978.
4. Harley CB, Futcher AB and Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460, 1990.
5. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK and Allshire RC: Telomere reduction in human colorectal carcinoma and with ageing. Nature 346: 866-868, 1990.
6. Counter CM, Botelho FM, Wang P, Harley CB and Bacchetti S: Stabilisation of short telomeres and telornerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 68: 3410-3414, 1994.
7. Blackburn EH: Telomeres: no end in sight. Cell 77: 621-623, 1994.
8. Zakian VA: Telomeres: beginning to understand the end. Science 270: 1601-1607, 1995.
9. Wellinger RJ and Sen D: The DNA structures at the ends of eukaryotic chromosomes. Eur J Cancer 33: 735-749, 1997.
10. Tommerup H, Dousmanis A and De Lange T: Unusual chromatin in human telomeres. Mol Cell Biol 14: 5777-5785, 1994.
11. Makarov VL, Lejnine S, Bedoyan J and Langmore JP: Nucleosomal organization of telomere-specific chromatin in rat. Cell 73: 775-787, 1993.
12. Smith S, De Lanae T: TRF1, a mammalian telomeric protein. Trends Genet 13: 21-26, 1997.
13. Broccoli D, Smogorzewska A, Chong L and De Lange T: Human telomeres contain two distinct myb-related proteins, TRF1 and TRF2. Nat Genet 17: 231-235, 1997.
14. Olovnikov AM: Principles of marginotomy in template synthesis of polynucleotides. Dokl Akad Nauk 201: 1496-1499, 1971.
15. Olovnikov AM: A theory of marginotomy. J Theor Biol 41: 181-190, 1973.
16. Watson JD: Origin of concatameric T4 DNA. Nature New Biol 239: 197-201, 1972.
17. Greider CW: Telomerase biochemistry and regulation. In: Telomeres. Blackburn EH and Greider CW (eds). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp35-68, 1995.
18. Feng J, Funk WD, Wang S, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Y u J, et al: The RNA component of human telomerase. Science 269: 1238-1241, 1995.
19. Harrington L. McPhail T, Mar V, Zhou W, Oulton R, Amgen EST Program, Bass MB, Arruda l and Robinson MO: A mammalian telomerase-associated protein. Science 275: 973-977, 1997.
20. Nakayama J, Saito M, Nakamura H, Matsuura A and Ishikawa F: TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88: 875-884, 1997.
21. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA and Weinberg RA: hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90: 785-795, 1997.
22. Counter CM, Avilion AA, Le Feuvre CE, Stewart NG, Greider CW, Harley CB and Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11: 1921-1929, 1992.
23. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB and Landsdorp PM: Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 91: 9857-9860, 1994.
24. Lansdorp PM, Verwoerd NP, van de Rijke FM, Dradowska V, Little MT, Dirks RW, Rapp AK and Tanke HJ: Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 5: 685-691, 1996.
25. Martens UM, Zijlmans JMJM, Poon SS, Dragowska W, Yui J, Chavez EA, Ward RK and Lansdorp PM: Short telomeres on of human chromosome 17p. Nat Genet 18: 76-80, 1998.
26. Zijlmans JMJM, Martens UM, Poon SS, Raap AK, Tanke HJ, Ward RK and Lansdorp PM: Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats. Proc Natl Acad Sci USA 94: 7423-7428, 1997.
27. Lansdorp PM, Poon S, Chavez E, Dragowska V, Zijlmans M, Bryan T, Reddel R, Egholm M, Bacchetti S and Martens U: Telomeres in the hematopoietic system. In: Telomeres and Telomerase. Chadwick DJ and Cardew G (eds). John Wiley & Sons Ltd., West Sussex, pp209-222, 1997.
28. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, De Pinho RA and Greider CW: Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34, 1997.
29. Hayflick L and Moorhead PS: The serial cultivation of human diploid strains. Exp Cell Res 25: 585-621, 1961.
30. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW and Harley CB: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89: 10114-10118, 1992.
31. Harley CB: Telomeres and aging. In: Telomeres. Blackburn EH and Greider CW (eds). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp247-265, 1995.
32. Campisi J: The biology of replicative senescence. Eur J Cancer 33: 703-709, 1997.
33. Weng N-P, Levine BL, June CH and Kodes RJ: Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc Natl Acad Sci USA 92: 11091-11094, 1995.
34. Chang E and Harley C: Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 92: 11190-11194, 1995.
35. Bodnar AG, Quellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S and Wright WE: Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352, 1998.
36. Harley CB, Vaziri H, Counter CM and Allsopp RC: The telomere hypothesis of cellular aging. Exp Gerontol 27: 375-382, 1992.
37. Allshire RC, Dempster M and Hastie ND: Human telomerase contain at least three types of G-rich repeats distributed nonrandomly. Nucleic Acids Res 17: 4611-4627, 1989.
38. Levy MZ, Allsopp RC, Futcher B, Greider CW and Harley CB: Telomere end-replication problem and cell aging. J Mol Biol 225: 951-960, 1992.
39. Allsopp RC and Harley CB: Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 219: 130-136, 1995.
40. Lansdorp PM: Lessons from mice without telomerase. J Cell Biol 139: 309-312, 1997.
41. De Lange T: Telomere dynamics and genome instability in human cancer. In: Telomeres. Blackburn EHG and C.W. (eds). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp265-293, 1995.
42. Sandell LL and Zakian VA: Loss of a yeast telomere: arrest, recovery and chromosome loss. Cell 75: 729-739, 1993.
43. Zakian VA: Telomere functions: lessons from yeast. Trends Cell Biol 6: 29-33, 1996.
44. Melek M and Shippen DE: Chromosome healing: spontaneous and programmed de novo telomere formation by telomerase. Bioessays 18: 301-308, 1996.
45. Cornells RS, van de Vijver M, Vos CBJ, Cleton-Jansen AM, Vijver MJ, Peterse JL, Khan PM, Borresen AL, Cornelisse CJ and Devilee P: Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cancer Res 54: 4200-4206, 1994.
46. Makos-Wales M: p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1: 570-577, 1995.
47. Seizinger BR, Klinger HP, Junien C, Nakamura Y, Le Beau M, Cavenee W. Emanuel B, Ponder B, Naylor S, Mitelmann F, Louis D, Menon A, Newsham I, Decker J, Kaelbling M, Henry I and Deimling AV: Report on the committee on chromosome and gene loss in human neoplasia. Cytogenet Cell Cenet 58: 1080-1096, 1991.
48. De Lange T, Shiue L, Myers MR, Cox DR, Naylor SL, Killery AM and Varmus HE: Structure and variability of human chromosome ends. Mol Cell Biol 10: 518-527, 1990.
49. Engelhardt M, Albanell J, Drullinsky P, Man W, Guillem J, Scher H, Reuter V and Moore MAS: Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon and sarcoma. Clin Cancer Res 3: 1849-1857, 1997.
50. Engelhardt M, Drullinsky P, Guillem J and Moore MAS: Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res 3: 1931-1941, 1997.
51. Yamada O, Oshimi K, Motoji T and Mizoguchi H: Telomeric DNA in normal and leukemic blood cells. J Clin Invest 95: 1117-1123, 1995.
52. Chadeneau C, Hay K, Hirte HW, Gallinger S and Bacchetti S: Telomerase activity associated with aquisition of malignancy in human colorectal cancer. Cancer Res 55: 2533-2536, 1995.
53. Suehara N, Mizumoto K, Muta T, Tominaga Y, Shimura H, Kitajima S, Hamasaki N, Tsuneyoshi M and Tanaka M: Telomerase elevation in pancreatic ductal carcinoma compared to non-malignant pathological stages. Clin Cancer Res 3: 993-998, 1997.
54. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, Kajiyama G and Ide T: Telomerase activity in human liver tissue: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 55: 2734-2736, 1995.
55. Counter CM, Hirte HW, Bacchetti S and Harley CB: Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 91: 2900-2904, 1994.
56. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, Piatyszek MA and Shay JW: Telomerase activity in small cell and non-small cell lung cancers. J Natl Cancer Inst 87: 895-902, 1995.
57. Mehle C, Ljungberg B and Roos G: Telomere shortening in renal cell carcinoma. Cancer Res 54: 236-241, 1994.
58. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW and Coffey DS: Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 56: 218-222, 1996.
59. Iwama H, Ohyashiki K, Ohyashiki JH, et at: The relationship between telomere length and therapy-associated cytogenetic responses in patients with chronic myeloid leukemia. Cancer 79: 1552-1560, 1997.
60. Adamson DJA, King DJ and Haites NE: Significant telomere shortening in childhood leukemia. Cancer Genet Cytogenet 61: 204-206, 1992.
61. Shay JW, Werbin H and Wright WE: Telomeres and telomerase in human leukemias. Leukemia 10: 1255-1261, 1996.
62. Engelhardt M, Ozkaynak MF, Drullinsky P, Sandoval C, Tugal O, Jayabose S and Moore MAS: Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy. Leukemia 12: 13-24, 1998.
63. Legare RD, Gribben JG, Maragh M, Hermanowski-Vosatka A, Roach S, Tantravahi R, Nadler LM and Gilliland DG: Prediction of therapy-related acute myelogenous leukemia (AML) and myelo-dysplastic syndrome (MDS) after autoiogous bone marrow transplant (ABMT) for lymphoma. Am J Hematol 56: 45-51, 1997.
64. Kishi K, Takahashi S, Gondo H, Shiobara S, Kanamaru A, Kato S, Hirabayashi N, Moriyama Y, Harada M, Asano S, Hara H and Shibata A: Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes. Bone Marow Transplant 19: 461-466, 1997.
65. Podesta M, Piaggio G, Frassoni F, Pitto A, Mordini N, Bregante S, Valeriani A and Bacigalupo A: Deficient reconstitution of early progenitors after allogeneic bone marrow transplantation. Bone Marrow Transplant 19: 1011-1017, 1997.
66. Wynn RF, Cross MA, Hatton C, Will AM, Lashford LS, Dexter TM and Testa NG: Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet 351: 178-181, 1998.
67. Notaro R, Cimmino A Tabarini D, Rotoli B and Luzzatto L: In vivo telomere dynamics of human hematopoietic stem cells. Proc Natl Acad Sci USA 94: 13782-13785, 1997.
68. Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W and Moore MAS: Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 90: 182-193, 1997.
69. Chiu CP, Dragowska W, Kim NW, Vaziri H, Yui J, Thomas TE, Harley CB and Lansdorp PM: Differential expression of telomerase activity in hematopoietic progenitors from adult bone marrow. Stem Cells 14: 239-248, 1996.
70. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatzszek MA, Shay JW, Ishioka S and Yamakido M: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155: 3711-3715, 1995.
71. Counter CM, Gupta J, Harley CB, Leber B and Bacchetti S: Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85: 2315-2320, 1995.
72. Broccoli D, Young JW and De Lange T: Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 92: 9082-9086, 1995.
73. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
74. Piatyszek MA, Kim NW, Weirich SL, Hiyama K, Hiyama E, Wright WE and Shay JW: Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 17: 1-15, 1995.
75. Nakashio R, Kitamoto M, Tahara H, Nakanishi T, Ide T and Kajiyama G: Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Int J Cancer 74: 141-147, 1997.
76. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA and Shay JW: Telomerase activity in human breast cancer. J Natl Cancer Inst 88: 116-122, 1996.
77. Haugen BR, Nawaz S, Markham N, Hashizumi T, Shroyer AL, Werness B and Shroyer KR: Telomerase activity in benign and malignant thyroid tumors. Thyroid 7: 337-342, 1997.
78. Califano J, Ahrendt SA, Meininger G, Koch WM, Westra WH and Sidransky D: Telomerase activity in oral rinses from head and neck squamous cell cancer patients. Cancer Res 56: 5720-5722, 1996.
79. Yoshida K, Sugino T, Goodison S, Warren BF, Nolan D, Wadsworth S, Mortensen NJ, Toge T, Tahara E and Tarin T: Detection of telomerase activity in exfoliated cancer cells in colonie luminal washings and its related clinical implications. Br J Cancer 75: 548-553, 1997.
80. Yoshida K, Sugino T, Tahara H, Woofman A, Bolodeoku J, Nargund V, Fellows G, Goodison S, Tahara E and Tarin T: Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 79: 362-369, 1997.
81. Kinoshita H, Ogawa O, Kakehi Y, Mishina M, Mitsumori K, Itoh N, Yamada H, Terachi T and Yoshida O: Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J Natl Cancer Inst 89: 724-730, 1997.
82. Dalbagni G, Han W, Zhang Z-F, Cordon-Cardo C, Saigo P, Fair W, Herr H, Kim N and Moore MAS: Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Clin Cancer Res 3: 1593-1598, 1997.
83. Hiyama E, Kodama T, Shinbara K, Iwao T, Itoh M, Hiyama K, Shay JW, Matsuura Y and Yokoyama T: Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 57: 326-331, 1997.
84. Holt SE, Wright WE and Shay JW: Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 16: 2932-2939, 1996.
85. Umbrich CB, Saji M, Westra WH, Udelsman R, Zeiger MA and Sukumar S: Telomerase activity: a marker to ditinguish follicular thyroid adenoma from carcinoma. Cancer Res 57: 2144-2147, 1997.
86. Hiyama E, Hiyama K, Yokoyama T, Matssra Y, Piatyszek MA and Shay JW: Correlating telomerase activity levels with human neuroblastoma outcome. Nat Med 3: 249-255, 1995.
87. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek MA, Shay JW and Matsuura Y: Telomerase activity in gastric cancer. Cancer Res 55: 3258-3262, 1995.
88. Ohyashiki JH, Ohyashiki K, Iwama H, Hayashi S, Toyama K and Shay JW: Clinical implications of lelomerase activity levels in acute leukemia. Clin Cancer Res 3: 619-625, 1997.
89. Zhang W, Piatyszek MA, Kobayashi T, Estey E, Andreeff M, Deisseroth AB, Wright WE and Shay JW: Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res 1: 799-803, 1996.
90. Bednarek AK, Sahin A, Brenner AJ, Johnston DA and Aldaz CM: Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage. Clin Cancer Res 3: 11-16, 1997.
91. Tsao J-I, Zhao Y, Lukas J Yang X, Shah A. Press M and Shibata D: Telomerase activity in normal and neoplastic breast. Clin Cancer Res 3: 627-631, 1997.
92. Kyo S, Kanaya T, Ishikawa H, Ueno H and Inoue M: Telomerase activity in gynecological tumors. Clin Cancer Res 2: 2023-2028, 1996.
93. Bryan TM, Englezou A, Gupta J, Bacchetti S and Reddel RR: Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240-4248, 1996.
94. Van Steensel B and De Lange T: Control of telomere length by the human telomeric protein TRF1. Nature 385: 740-743, 1997.
95. Chong L, van Steensel B, Broccoli D, Erdjument-Bromage H, Hanish J, Tempst P and De Lange T: A human telomeric protein. Science 270: 1663-1667, 1995.
96. Marcand S, Gilson E and Shore D: A protein-counting mechanism for telomere length regulation in yeast. Science 275: 986-990, 1997.
97. Holt SE, Shay JW and Wright WE: Refining the telomeretelomerase hypothesis of aging and cancer. Nat Biol 14: 836-839, 1996.
98. Chadeneau C, Siegel P, Harley CB, Muller WJ and Bacchetti S: Telomerase activity in normal and malignant murine tissues. Oncogene 11: 893-898, 1995.
99. Norrback KF, Dahlenborg K, Carlsson R and Roos G: Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 88: 222-229, 1996.
100. Harle-Bachor C and Boukamp P: Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93: 6476-6481, 1996.
101. Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, Yamamoto H, Ide T and Utakoji T: Telomerase activity in normal human epithelial cells. Oncogene 13: 433-439, 1996.
102. Igarashi H and Sakaguchi N: Telomerase activity is induced in human peripheral B lymphocytes by the stimulation to antigen receptor. Blood 89: 1299-1307, 1997.
103. Albanell J, Han W, Mellado B, Gunawardane R, Scher HI, Dmitrovsky E and Moore MA: Telornerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Res 56: 1503-1508, 1996.
104. Belair CD, Yeager TR, Lopez PM and Reznikoff CA: Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA 94: 13677-13682, 1997.
105. Holt SE, Gollahon LS, Willingham T, Barbosa M and Shay JW: p53 levels in human mammary epithelial cells expressing wild-type and mutant human papillomavirus type 16 (HPV-16) E6 proteins: relationship to reactivation of telomerase and immortalization. Int J Oncol 8: 263-270, 1996.
106. Greider CW: Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 95: 90-92, 1998.
107. Brousset P, Saati TA, Chaouche N, Zenou R-C, Schlaifer D, Chittal S and Delsol G: Telomerase activity in reactive and neoplastic lymphoid tissues: infrequent detection of activity in Hodgkin's disease. Blood 89: 26-31, 1997.
108. Albanell J, Leonardo F, Rusch VW, Engelhardt M, Langenfeld J, Han W, Klimstra D, Vemkatraman E, Moore MAS and Dimitrovsky E: High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic staee. J Natl Cancer Inst 89: 1609-1614. 1997.
109. Langford LA, Piatyszek MA, Xu R, Schold SC Jr and Shay JW: Telomerase activity in human brain tumors. Lancet 346: 1267-1268, 1995.